Use of stigmasta-4-en-3-one in the treatment of androgen depende

Details Use of stigmasta-4-en-3-one in the treatment of androgen depende Use of stigmasta-4-en-3-one in the treatment of androgen depende

1992-04-29

1993-11-23

Waddell, Frederick E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Cyclopentanohydrophenanthrene ring system doai

A61K 3156

Patent

active

052644286

ABSTRACT:
A pharmaceutical preparation which comprises stigmasta-4-en-3-one as the active ingredient. This active ingredient can be used for the treatment of androgen-dependent diseases, especially for the treatment of benign prostatic hyperplasia.

REFERENCES:
patent: 3647829 (1972-03-01), Kruger et al.
Chemical Abstracts, 96(2): 11546r, 1981.
Chemical Abstracts, 99(12): 93577a, 1983.
Chemical Abstracts, 104(22): 193257m, 1986.
Chemical Abstracts, 105(18): 158615a, 1986.
Chemical Abstracts, 106(4): 23080x, 1986.

Affiliated with

Also associated with

Rating

Use of stigmasta-4-en-3-one in the treatment of androgen depende does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of stigmasta-4-en-3-one in the treatment of androgen depende, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of stigmasta-4-en-3-one in the treatment of androgen depende will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1849008